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Is the Link Real?*Atul Malhotra, MD,y Tomas G. Neilan, MD,z Kathleen Sarmiento, MD, MPHyI ncreasingly compelling data link obstructivesleep apnea (OSA) to cardiovascular impact, in-dependent of known comorbidities (1). OSA is
estimated to affect w10% of individuals (2), a ﬁgure
that has been increasing due to the obesity pandemic
and an aging population, both of which contribute to
OSA risk (3). In addition, diagnostic technology has
become more sensitive over time such that the earlier
prevalence of OSA was likely underestimated, and
the prevalence in patients with cardiovascular dis-
ease is likely to be considerably higher than 10%
(estimated 50% to 80%), although rigorous epide-
miological data are still evolving (4,5). OSA is
deﬁned by repetitive collapse of the pharyngeal
airway during sleep, resulting in ﬂuctuations in intra-
thoracic pressure, hypoxemia, hypercapnia, and cate-
cholamine surges (6). Hypoxemia and hypercapnia
generate pulmonary artery vasoconstriction, leading
to right heart strain. In addition to autonomic abnor-
malities, inﬂammatory pathways have been impli-
cated in OSA, perhaps as a result of hypoxemia plus
obesity (7).
Although OSA has been associated with atrial
ﬁbrillation (AF) (8), deﬁnitive causal data are still
lacking (9). Several theoretical possibilities may
explain an interaction between OSA and AF:*Editorials published in the Journal of the American College of Cardiology
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proportions, their association may be based on
chance alone, perhaps resulting from common risk
factors such as obesity and aging. However,
epidemiological data suggest that OSA indepen-
dent of obesity is associated with AF; that obesity
independent of OSA is associated with AF, partic-
ularly in younger individuals (10); and that weight
loss in obese individuals (11) or primary treatment
of OSA (8,12) can reduce the burden of AF. Thus,
the link between OSA and AF seems more than an
association due to chance.
2. OSA may predispose to AF via some combination
of intrathoracic pressure swings yielding atrial
chamber stretch, surges in catecholamines leading
to elevated left ventricular end-diastolic pressure,
and, perhaps, increased systemic inﬂammation in
OSA leading to AF risk. OSA has been associated
with ventricular remodeling/ﬁbrosis and atrial
chamber dilation, both of which are contributors
to AF (13).
3. AF could theoretically worsen OSA. Reduced for-
ward ﬂow can destabilize ventilatory control, and
elevated left atrial pressure may cause ventilatory
control instability (6,14). Whether restoration of
normal sinus rhythm leads to improvement in OSA
severity is unclear.
4. The primary mechanisms for AF could be caused
by OSA (15). Indeed, unless OSA is addressed,
pulmonary vein ablation to eliminate triggers has
shown high AF recurrence rates in patients with
OSA. Mechanistically, OSA may create particular
difﬁculty in achieving durable pulmonary vein
isolation, contribute to trigger formation outside
the pulmonary veins, or promote AF-maintaining
substrates by swings in intrathoracic pressure and
atrial stretch. For instance, localized electrical
circuits (rotors) in diverse bi-atrial locations may
sustain human AF (16), and ablating such sources
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2025in patients with OSA can improve success over
pulmonary vein isolation alone (17).
In this issue of the Journal, important light is shed
on the link between AF and OSA via a sophisticated,
newly developed animal model. Iwasaki et al. (18)
provide evidence that repetitive induction of apnea
promotes AF in a mechanically ventilated rat model.
Compared with 2 groups of control animals, with
open respiration (no ventilator) or sham ventilation
(no obstruction), those with induced apnea dis-
played substantially enhanced AF inducibility on
invasive electrophysiological testing, slowing of atrial
conduction velocity on optical mapping, down-
regulation of connexin-43 (important for electrical
wave propagation), and increased atrial ﬁbrosis. The
authors also observed marked changes in left ven-
tricular structure, with hypertrophy, dilation, and
diastolic dysfunction. The authors concluded that
induced obstruction caused atrial conduction to slow
and promoted AF inducibility. These mechanistic
data are likely to provide reassurance of the clinical
importance of the observed associations.SEE PAGE 2013Despite the novel ﬁndings, a number of questions
remain for both clinicians and scientists. First, does
the model of Iwasaki et al. (20) mirror clinical OSA?
Other than the animals’ obvious lack of metabolicabnormalities and obesity, the technical aspects of
induced obstruction seem appropriate. Electrophysi-
ologically, there has been recent doubt that refractory
period shortening contributes to human AF (19),
despite earlier studies (20). Indeed, Iwasaki et al. did
not observe shortened refractoriness, whereas their
results implicating conduction slowing from ﬁbrosis
and connexin down-regulation in causing AF are
compelling. Second, do these results support ongoing
clinical studies testing whether patients with AF
should routinely be screened for OSA? Third, these
data suggest that AF related to OSA is substrate based
rather than trigger based, explaining the limitations
of pulmonary vein isolation and further motivating
approaches to deﬁne AF-maintaining substrates.
Fourth, does AF promote OSA, and if so, does
treatment of AF improve OSA? Given the recent
emphasis on the multifactorial nature of OSA patho-
genesis, perhaps OSA patients with unstable ven-
tilatory control would be particularly amenable to
addressing issues regarding AF and cardiac function
(6). We applaud Iwasaki et al. (20) for these new
insights.
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